Trials / Withdrawn
WithdrawnNCT04534140
Skin Hydration in Persons With Acne After Dietary Supplementation With Botanical Antioxidants
Evaluating the Effect of an Antioxidant Nutraceutical on Skin Health, as Measured by Investigator Global Assessment, Quality-of-Life, and Corneometry, in Persons With Mild to Moderately Severe Facial Acne Vulgaris
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of California, Los Angeles · Academic / Other
- Sex
- All
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
Antioxidants have been studied for their abilities to combat reactive oxygen species in a multitude of conditions. This study aims to assess whether the botanical dietary supplement 'Halo Beauty Kiwi Booster' (HBKB), taken orally daily for 8 weeks, can assist with Acne vulgaris as well as skin hydration and quality of life for those with acne.
Detailed description
The study will be a 2-armed investigational trial with one group receiving botanical dietary supplement and one placebo group provided with the similar supplement vehicle. The trial will be double-blind, randomized, parallel-group study. The investigational group will receive the botanical dietary supplement 'Halo Beauty Kiwi Booster' (HBKB), to be taken orally daily for 8 weeks. Control group participants will receive the HBKB botanical dietary supplement vehicle as a placebo to be taken orally daily for 8 weeks.Participants will have their skin assessed
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | HBKB Capsule | The botanical dietary supplement 'Halo Beauty Kiwi Booster' (HBKB) taken daily orally. |
| OTHER | HBKB Supplement Vehicle | Control group participants will take one capsule of the HBKB botanical dietary supplement vehicle orally, once daily |
Timeline
- Start date
- 2021-01-25
- Primary completion
- 2023-01-24
- Completion
- 2023-01-24
- First posted
- 2020-09-01
- Last updated
- 2021-01-28
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04534140. Inclusion in this directory is not an endorsement.